Role of Biosensing Technology for NeuroAIDS Management.
作者信息
Jayant R D, Nair M
机构信息
Center of Personalized Nanomedicine, Institute of Neuro Immune Pharmacology, Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL-33199, USA.
出版信息
J Biosens Bioelectron. 2016 Mar;7(1). doi: 10.4172/2155-6210.1000e141. Epub 2016 Feb 29.
Abstract
摘要
相似文献
1
Role of Biosensing Technology for NeuroAIDS Management.
J Biosens Bioelectron. 2016 Mar;7(1). doi: 10.4172/2155-6210.1000e141. Epub 2016 Feb 29.
2
Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
Biomol Concepts. 2018 May 8;9(1):33-42. doi: 10.1515/bmc-2018-0005.
3
NeuroAIDS in sub-Saharan Africa: a clinical review.
Ann Afr Med. 2013 Jan-Mar;12(1):1-10. doi: 10.4103/1596-3519.108242.
4
Friends Turn Foe-Astrocytes Contribute to Neuronal Damage in NeuroAIDS.
J Mol Neurosci. 2019 Oct;69(2):286-297. doi: 10.1007/s12031-019-01357-1. Epub 2019 Jun 25.
5
Latest trends in drugs of abuse - HIV infection and neuroAIDS.
Future Virol. 2013 Feb;8(2):121-127. doi: 10.2217/fvl.12.134.
6
NeuroAIDS: virological aspects of HIV infection.
J Biol Regul Homeost Agents. 2013 Apr-Jun;27(2 Suppl):115-28.
7
The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies.
Database (Oxford). 2015 Jul 30;2015:bav074. doi: 10.1093/database/bav074. Print 2015.
8
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.
Mol Biomed. 2020;1(1):15. doi: 10.1186/s43556-020-00019-8. Epub 2020 Dec 10.
9
Global NeuroAIDS roundtable.
J Neurovirol. 2013 Feb;19(1):1-9. doi: 10.1007/s13365-012-0143-9. Epub 2013 Jan 26.
10
Terahertz Metamaterials for Biosensing Applications: A Review.
Biosensors (Basel). 2023 Dec 21;14(1):3. doi: 10.3390/bios14010003.
引用本文的文献
1
CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening.
Drug Discov Today. 2020 Feb;25(2):456-465. doi: 10.1016/j.drudis.2019.11.010. Epub 2019 Nov 26.
2
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Drug Des Devel Ther. 2019 Oct 18;13:3591-3605. doi: 10.2147/DDDT.S218708. eCollection 2019.
3
Advancements in nano-enabled therapeutics for neuroHIV management.
Int J Nanomedicine. 2016 Sep 1;11:4317-25. doi: 10.2147/IJN.S109943. eCollection 2016.
本文引用的文献
1
An Ultrasensitive Electrochemical Immunosensor for HIV p24 Based on Fe₃O₄@SiO₂ Nanomagnetic Probes and Nanogold Colloid-Labeled Enzyme-Antibody Copolymer as Signal Tag.
Materials (Basel). 2013 Mar 25;6(4):1255-1269. doi: 10.3390/ma6041255.
2
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS.
Adv Drug Deliv Rev. 2016 Aug 1;103:202-217. doi: 10.1016/j.addr.2016.02.008. Epub 2016 Mar 2.
3
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e110-9. doi: 10.1097/QAI.0000000000000748.
4
Electrochemical sensing method for point-of-care cortisol detection in human immunodeficiency virus-infected patients.
Int J Nanomedicine. 2015 Jan 19;10:677-85. doi: 10.2147/IJN.S75514. eCollection 2015.
5
Point of Care Technologies for HIV.
AIDS Res Treat. 2014;2014:497046. doi: 10.1155/2014/497046. Epub 2014 Jan 21.
6
Effects of diamond-FET-based RNA aptamer sensing for detection of real sample of HIV-1 Tat protein.
Biosens Bioelectron. 2013 Feb 15;40(1):277-82. doi: 10.1016/j.bios.2012.07.048. Epub 2012 Aug 21.
7
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007120. doi: 10.1101/cshperspect.a007120.
8
Picomolar detection of protease using peptide/single walled carbon nanotube/gold nanoparticle-modified electrode.
ACS Nano. 2008 May;2(5):1051-7. doi: 10.1021/nn8000774.
9
An electrochemical approach for the detection of HIV-1 protease.
Chem Commun (Camb). 2007 Oct 7(37):3829-31. doi: 10.1039/b707140j.
10
Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy.
Clin Immunol. 2001 Jun;99(3):347-52. doi: 10.1006/clim.2001.5033.
Zotero 插件